Senior insider sale
BRIDGEBIO PHARMA, INC. — senior position signals high conviction
$4.21M
64.92K shares
What this filing means
ELLIS ANDREA plans to sell 64.92K shares of BRIDGEBIO PHARMA, INC. valued at approximately $4.21M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/4/2026ACC: 0001950047-26-002147
64.92K
Shares to sell
$4.21M
Approx. market value
64.92K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
3/4/2026
64.92KTotal acquired64.92K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2026 | Stock Option Exercise Cash | 64.92K | — |
| Total | 64.92K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
64.92K
Market value
$4.21M
3/4/2026
Total
Units
64.92K
Value
$4.21M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/4/2026 | 64.92K | $4.21M | NASDAQ | Planned |
| Total | 64.92K | $4.21M | ||